On October 30, 2017, Golden Meditech Holdings Limited announced that its Board of Directors intends to commence a repurchase program. Under the program, the company will repurchase up to 65,638,518 TDR, representing approximately 2.21% of the shares in issue, at a repurchase price of TWD 4.45 per TDR for a total of TWD 292.09 million. The repurchase offer is subject to the approval of proposed voluntary delisting of TDR by Taiwan Stock Exchange.